Brief: Clearpoint Neuro And UCB Enter License Agreement For Gene Therapy Drug Delivery

Clearpoint Neuro

24/05/2023 14:27

May 24 (Reuters) - Clearpoint Neuro Inc  CLPT.O :
    * CLEARPOINT NEURO AND UCB ENTER LICENSE AGREEMENT FOR GENE
THERAPY DRUG DELIVERY
    * CLEARPOINT NEURO INC - FURTHER FINANCIAL DETAILS OF
AGREEMENT
WERE NOT DISCLOSED
    * CLEARPOINT NEURO INC- UCB TO UTILIZE CO'S PROPRIETARY
TECHNOLOG,
SERVICES IN CONNECTION WITH DEVELOPMENT OF UCB'S GENE THERAPY
PRODUCTS

Source text for Eikon:  ID:nGNEbpRknX 
Further company coverage:  CLPT.O 

 ((reuters.briefs@thomsonreuters.com;))